A cytotoxic fusion protein based on ephrin-A5, which targets EphA3, EphA2, and EphB2, selectively kills GBM cells with remarkable potency (IC50 ≈ 10−11 M; Ferluga et al., 2016). Here, EPHA3 is linked to glioblastoma.